Non-Pharmaceutical Intervention for Cirrhotic Cramps Reduction: The NICCles Trial
1 other identifier
interventional
82
1 country
1
Brief Summary
This clinical trial is evaluating the feasibility of using a non-pharmaceutical treatment to improve the symptoms and severity of muscle cramps in patients with cirrhosis. Eligible participants will be randomized to the treatment arm or control group. The treatment phase of the study will last 28 days. Information about participants will be collected including surveys and assessments throughout the study. Please note that only the participants randomized to experimental intervention group (Household Remedy) will be told what the treatment is during the study period. At the conclusion of the study (time of the final follow-up assessments), all participants will be debriefed on the use of concealment in this study as outlined in the protocol regarding the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 24, 2020
CompletedFirst Posted
Study publicly available on registry
December 2, 2020
CompletedStudy Start
First participant enrolled
January 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 2, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 2, 2021
CompletedDecember 3, 2021
December 1, 2021
11 months
November 24, 2020
December 2, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction in cramp severity after 28-days as measured by the Visual Analog Scale for Cramps
This is a scale that is numbered from 0 (means no cramps) to 10 (worst cramps imaginable).
28 days
Secondary Outcomes (4)
Number of cramp-days per person
28 days
Number of days with cramp severity less than 5 on the Visual Analog Scale for Cramps
28 days
Number of cramps during study
28 days
Change in sleep quality based on the Pittsburgh Sleep Quality Index (PSQI)
baseline, 28 days
Study Arms (2)
Household Remedy
EXPERIMENTALTap Water
PLACEBO COMPARATORInterventions
If the participant experiences a muscle cramp one tablespoon (one sip) of the household product will be taken. The treatment phase of the study will be for 28 days.
If the participant experiences a muscle cramp one tablespoon (one sip) of tap water will be taken. The treatment phase of the study will be for 28 days.
Eligibility Criteria
You may qualify if:
- Diagnosis of cirrhosis (criteria per protocol will be used)
- History of painful muscle spasms, cramps, or charley horses that come on while resting (they had to have happened 4 times in the past month and bother the participant)
You may not qualify if:
- Non-English speaking
- Unable or unwilling to provide consent
- History of liver transplant
- History of multiple sclerosis
- History of cerebral palsy
- History of stroke with paralysis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elliot Tapper, MD
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Internal Medicine
Study Record Dates
First Submitted
November 24, 2020
First Posted
December 2, 2020
Study Start
January 18, 2021
Primary Completion
December 2, 2021
Study Completion
December 2, 2021
Last Updated
December 3, 2021
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share